PharmiWeb19h
Global Progressive Fibrosing Interstitial Lung Disease Market Projected to Reach USD 8654.1 Million by 2033 at a 6.2% of CAGR
The Progressive Fibrosing Interstitial Lung Disease (PF-ILD) market is currently valued at USD 4,742.2 Million in 2023 and is ...
JD Supra15h
Classified (Bi-)Monthly: A Roundup of Class Action Decisions From Federal Appellate Courts July and August 2024
The Roundup covers notable class action decisions from federal appellate courts and notable Supreme Court class action cert petitions.
Future Market Insights17h
Global Hidradenitis Suppurativa Treatment Market Projected to Reach USD 1,240.9 Million by 2033, With a CAGR of 4.97%
The major players in the market are Inflarx, Novartis Pharmaceuticals ... Boehringer Ingelheim, Eli Lilly, Moonlake ...
Roche comes out against allowing takeover of drug manufacturer Catalent
The CEO of pharmaceuticals giant Roche has urged authorities to block the takeover of contract drug manufacturer Catalent by ...
Le Lézard19h
GoodRx Announces New Affordability Programs for Menopause Hormone Therapies
Today, GoodRx , the leading prescription savings platform in the U.S., announced the availability of new affordability programs for menopause hormone therapies by Pfizer. Through the reach and scale ...
PharmiWeb2h
Global Rx-to-OTC Switches Market Set to Reach USD…
According to a recent report by Future Market Insights (FMI), the global Rx-to-OTC switches market is projected to experience exceptional growth, reaching a valuation of USD 66.5 billion by 2033. This ...